Tao Synergies Inc. (TAOX)

TAO Synergies Inc. is a New York-based company whose strategy centers on TAO, the native cryptocurrency of Bittensor, a decentralized blockchain network designed for machine learning and artificial intelligence. The company was formerly known as Synaptogenix, Inc., a biopharmaceutical developer, and adopted its current name in 2025.

The company acquires and holds TAO tokens as its primary treasury asset and may stake them within the Bittensor network to earn rewards. Its approach is intended to give public-market investors exposure to the Bittensor ecosystem, in which participants contribute and evaluate machine learning models in exchange for token incentives.

TAO Synergies' common stock trades on the Nasdaq under the ticker TAOX.